Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹9,307 Cr
Revenue (TTM)
₹768 Cr
Net Profit (TTM)
₹159 Cr
ROE
19.8 %
ROCE
30.3 %
P/E Ratio
58.4
P/B Ratio
10.3
Industry P/E
45.18
EV/EBITDA
27.8
Div. Yield
0.2 %
Debt to Equity
0
Book Value
₹93.9
EPS
₹15.6
Face value
1
Shares outstanding
96,694,508
CFO
₹879.68 Cr
EBITDA
₹1,283.36 Cr
Net Profit
₹653.21 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vijaya Diagno
| -9.3 | 0.7 | -6.6 | 8.0 | 34.6 | -- | -- |
|
BSE Healthcare
| -3.1 | -3.4 | -6.0 | 7.2 | 23.7 | 13.7 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Vijaya Diagno
| -0.2 | 56.5 | 54.6 | -25.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vijaya Diagno
|
962.8 | 9,306.9 | 768.1 | 159.9 | 29.2 | 19.3 | 58.4 | 10.3 |
| 270.0 | 660.1 | 230.1 | 23.5 | -- | 28.7 | 29.8 | 5.2 | |
| 1,378.6 | 23,076.5 | 2,662.8 | 533.1 | 22.9 | 24.1 | 43.7 | 9.0 | |
| 664.3 | 26,583.2 | 3,626.9 | 315.0 | 15.0 | 13.3 | 88.4 | 11.4 | |
| 599.1 | 1,941.1 | 766.3 | 80.5 | 15.7 | 8.9 | 24.1 | 2.1 | |
| 456.0 | 9,470.7 | 1,566.5 | 169.5 | 14.8 | 12.7 | 56.3 | 6.3 | |
| 545.2 | 5,483.6 | 755.8 | 67.1 | -- | 13.8 | 81.7 | 5.6 | |
| 267.6 | 854.6 | 1,231.3 | 29.1 | -4.7 | 4 | 32.8 | 1.3 | |
| 262.0 | 1,359.3 | 294.1 | 32.4 | 17.4 | 15.1 | 40.8 | 5.7 | |
| 390.5 | 6,217.8 | 792.3 | 135.5 | 23.5 | 26.4 | 45.2 | 9.3 |
IPO update: Vijaya Diagnostic Centre
3 min read•By Udhayaprakash
Vijaya Diagnostic IPO: Information analysis
6 min read•By Danish Khanna and Udhayaprakash
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular... diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India. Read more
Incorporated
2002
Chairman
Sura Surendranath Reddy
Managing Director
Sura S Reddy
Headquarters
Hyderabad, Telangana
Website
Looking for more details about Vijaya Diagnostic Centre Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Vijaya Diagnostic Centre Ltd is ₹962.80 (NSE) and ₹958.00 (BSE) as of 08-Apr-2026 IST. Vijaya Diagnostic Centre Ltd has given a return of 34.65% in the last 3 years.
The P/E ratio of Vijaya Diagnostic Centre Ltd is 58.37 times as on 08-Apr-2026, a 29 premium to its peers’ median range of 45.18 times.
The P/B ratio of Vijaya Diagnostic Centre Ltd is 10.25 times as on 08-Apr-2026, a 37 premium to its peers’ median range of 7.48 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
72.22
|
13.02
|
|
2024
|
54.69
|
9.91
|
|
2023
|
47.18
|
7.36
|
|
2022
|
40.70
|
9.57
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Vijaya Diagnostic Centre Ltd are Rs 1,180.00 and Rs 848.00 as of 09-Apr-2026.
Vijaya Diagnostic Centre Ltd has a market capitalisation of ₹ 9,307 Cr as on 08-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Vijaya Diagnostic Centre Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹33.95
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.